Showing results (101-110 of 132) with videos related to

Sort By:
Pageof 14
The Oncologist|August 27, 2024
Relacorilant plus nab-paclitaxel for the treatment of metastatic pancreatic ductal adenocarcinoma: results from the open-label RELIANT studyErkut H Borazanci, Nathan Bahary, Vincent Chung, et al.
JCO Precision Oncology|October 5, 2020
Identification of Actionable Fusions as an Anti-EGFR Resistance Mechanism Using a Circulating Tumor DNA AssayKatherine Clifton, Thereasa A Rich, Christine Parseghian, et al.
British Journal of Cancer|February 3, 2017
A phase 1 dose-escalation and expansion study of binimetinib (MEK162), a potent and selective oral MEK1/2 inhibitorJohanna C Bendell, Milind Javle, Tanios S Bekaii-Saab, et al.
JAMA Oncology|April 1, 2021
Assessment of Pembrolizumab Therapy for the Treatment of Microsatellite Instability-High Gastric or Gastroesophageal Junction Cancer Among Patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Clinical TrialsJoseph Chao, Charles S Fuchs, Kohei Shitara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2020
Open-label, Phase I Study of Nivolumab Combined with nab-Paclitaxel Plus Gemcitabine in Advanced Pancreatic CancerZev A Wainberg, Howard S Hochster, Edward J Kim, et al.
Future Oncology (London, England)|November 1, 2018
Maintenance avelumab versus continuation of first-line chemotherapy in gastric cancer: JAVELIN Gastric 100 study designMarkus Moehler, Min-Hee Ryu, Mikhail Dvorkin, et al.
The Lancet. Oncology|October 16, 2022
Bemarituzumab in patients with FGFR2b-selected gastric or gastro-oesophageal junction adenocarcinoma (FIGHT): a randomised, double-blind, placebo-controlled, phase 2 studyZev A Wainberg, Peter C Enzinger, Yoon-Koo Kang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2019
Results from a Phase IIb, Randomized, Multicenter Study of GVAX Pancreas and CRS-207 Compared with Chemotherapy in Adults with Previously Treated Metastatic Pancreatic Adenocarcinoma (ECLIPSE Study)Dung T Le, Vincent J Picozzi, Andrew H Ko, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2015
Lapatinib in Combination With Capecitabine Plus Oxaliplatin in Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma: TRIO-013/LOGiC--A Randomized Phase III TrialJ Randolph Hecht, Yung-Jue Bang, Shukui K Qin, et al.
Surgery|November 14, 2021
Pathological treatment response has different prognostic implications for pancreatic cancer patients treated with neoadjuvant chemotherapy or chemoradiotherapyShimpei Maeda, Michael A Mederos, Akhil Chawla, et al.
Pageof 14